ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.

TNXP Tonix Pharmaceuticals Holding Corporation

1.17
0.05 (4.46%)
18 Jun 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Tonix Pharmaceuticals Holding Corporation TNXP NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
0.05 4.46% 1.17 18:59:48
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
1.10 1.08 1.26 1.22 1.12
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
18/6/202407:00GLOBETonix Pharmaceuticals Presented Data Comparing Real-World..
17/6/202407:00GLOBETonix Pharmaceuticals Presented Poster of Tonmya™ for the..
14/6/202416:25EDGAR2Form 8-K/A - Current report: [Amend]
13/6/202416:24EDGAR2Form 8-K - Current report
13/6/202416:00GLOBETonix Pharmaceuticals Announces Closing of $4.0 Million..
12/6/202416:01EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
12/6/202408:00GLOBETonix Pharmaceuticals Announces Pricing of $4.0 Million..
11/6/202416:17GLOBETonix Pharmaceuticals Announces Proposed Public Offering
11/6/202415:49EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
10/6/202407:53EDGAR2Form 8-K - Current report
06/6/202410:21EDGAR2Form 8-K - Current report
06/6/202410:00GLOBETonix Pharmaceuticals Announces 1-for-32 Reverse Stock Split
06/6/202407:05EDGAR2Form 8-K - Current report
06/6/202407:00GLOBETonix Pharmaceuticals Announces Two Oral Presentations and..
05/6/202407:00GLOBETonix Pharmaceuticals Announces Poster Presentation at the..
03/6/202407:05EDGAR2Form 8-K - Current report
03/6/202407:00GLOBETonix Pharmaceuticals Presented New Data on Tonmya™..
30/5/202407:05EDGAR2Form 8-K - Current report
30/5/202407:00GLOBETonix Pharmaceuticals Announces Two Poster Presentations of..
29/5/202407:00GLOBETonix Pharmaceuticals Announces Two Oral Presentations and..
28/5/202407:00GLOBETonix Pharmaceuticals Announces Presentation at the 2024 BIO..
24/5/202416:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/5/202416:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/5/202416:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/5/202416:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/5/202416:16EDGAR2Form 8-K - Current report
22/5/202407:05EDGAR2Form 8-K - Current report
22/5/202407:00GLOBETonix Pharmaceuticals to Deliver an Oral Presentation and..
21/5/202407:07EDGAR2Form 8-K - Current report
21/5/202407:00GLOBETonix Pharmaceuticals Announces Key Findings from Initial..
15/5/202407:00GLOBETonix Pharmaceuticals to Present at the Alliance Global..
13/5/202415:56EDGAR2Form 8-K - Current report
13/5/202415:51EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/5/202415:30GLOBETonix Pharmaceuticals Reports First Quarter 2024 Financial..
24/4/202407:00GLOBETonix Pharmaceuticals Announces Presentation at Planet..
01/4/202415:15GLOBETonix Pharmaceuticals Reports Fourth Quarter and Full Year..
28/3/202408:32GLOBETonix Pharmaceuticals Announces Pricing of $4.4 Million..
25/3/202407:00GLOBETonix Pharmaceuticals Receives Rare Pediatric Disease..
21/3/202407:00GLOBETonix Pharmaceuticals Announces Poster Presentation..
20/3/202407:00GLOBETonix Pharmaceuticals Announces Selection of Two Contract..
19/3/202407:00GLOBETonix Pharmaceuticals Announces Transition to Fully..
12/3/202407:00GLOBETonix Pharmaceuticals Announces Presentation at BIO-Europe..
11/3/202407:05EDGAR2Form 8-K - Current report
11/3/202407:00GLOBETonix Pharmaceuticals Reports Improvement in “Brain Fog,” in..
07/3/202408:37GLOBENew to The Street Announces TV Episode 560 with its Five..
07/3/202407:06EDGAR2Form 8-K - Current report
07/3/202407:00GLOBETonix Pharmaceuticals Announces Publication in Psychiatry..
06/3/202416:01EDGAR2Form 4/A - Statement of changes in beneficial ownership of..
06/3/202407:05EDGAR2Form 8-K - Current report
06/3/202407:00GLOBETonix Pharmaceuticals Selects EVERSANA® to Support Launch..

Su Consulta Reciente

Delayed Upgrade Clock